Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Dynatrace, Inc. Director's Dealing 2019

Aug 3, 2019

30410_dirs_2019-08-02_c87bcb88-613a-4251-9128-a067b224ec5b.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Dynatrace, Inc. (DT)
CIK: 0001773383
Period of Report: 2019-07-31

Reporting Person: Van Siclen John (Director, Chief Executive Officer)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2019-07-31 Common Stock A 83000 $0.00 Acquired 2703827 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2019-07-31 Stock Option (Right to Buy) $16.00 A 553000 Acquired 2029-07-31 Common Stock (553000) Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 502025 Indirect
Common Stock 903645 Indirect
Common Stock 7531 Indirect

Footnotes

F1: Consists of Restricted Stock Units ("RSUs") issued under the Dynatrace, Inc. 2019 Equity Incentive Plan. Each RSU represents the right to receive one share of Common Stock.

F2: Shares held by the John W. Van Siclen 2019 Irrevocable Trust, for which the Concord Trust Company serves as trustee. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F3: Shares held by the Nancy R. Van Siclen 2019 Irrevocable Trust, for which the Concord Trust Company serves as trustee. The reporting person disclaims beneficial ownership of these securities, and the filing of this report is not an admission that the reporting person is the beneficial owner of these securities for purposes of Section 16 or for any other purpose.

F4: Stock options granted on July 31, 2019, 25% of which shall vest and become exercisable on August 15, 2020, with the remainder vesting in 12 equal quarterly installments thereafter.